BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

InfaCare Names Ronald Goldfuss CFO


10/19/2005 5:12:33 PM

NEPTUNE, N.J., Jan. 26 /PRNewswire/ -- Dr. Robert A. Vukovich, Chairman and Founder of InfaCare Pharmaceutical Corporation, and Mr. John R. Post, President and CEO of InfaCare, jointly announced today that E. Ronald Goldfuss will join the company as Chief Financial Officer effective February 1, 2005. InfaCare is a specialty pharmaceutical company focused on developing innovative therapies for neonates and older children. The company is based in Neptune, NJ.

The Board of Directors is pleased with this appointment," said Dr. Vukovich. "Ron's broad financial background as CFO with various start-up organizations, his fund-raising expertise and general operational experience make him an ideal individual to join InfaCare's management team. Together with John Post, President and CEO, and other senior managers, we now have the core leadership team in place to implement the business plans of our emerging specialty pharmaceutical company."

Mr. Goldfuss has served as Chief Financial Officer for several biomedical and technology organizations including Songbird Hearing Inc., CompuCyte Corporation, Vital Sciences Inc., and Spinnaker Software Corporation. He was instrumental in taking Spinnaker Software public and has considerable experience in raising equity and debt capital for private and public companies. He also has extensive experience in mergers and acquisitions, and in technology licensing.

Mr. Goldfuss received his AB in economics from Boston College and his MBA from the Wharton School, University of Pennsylvania. He earned his CPA while with Arthur Andersen & Co.

InfaCare Pharmaceutical Corporation is a privately held pharmaceutical company founded in 2001 by Dr. Robert A. Vukovich. The company is currently developing Stanate(R) for the treatment of hyperbilirubinemia (elevated bilirubin levels leading to jaundice and possible neurological damage) in neonates.

CONTACT: Nancy Bracken Tel: (732) 938-5885 Fax: (732) 751-9056 Website: http://www.infacarepharm.com/

InfaCare Pharmaceutical Corporation

CONTACT: Nancy Bracken, InfaCare Pharmaceutical Corporation,+1-732-938-5885, Fax: +1-732-751-9056



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES